About the network

The GABRIEL international scientific network was created to strengthen the research and training capabilities of local laboratories in developing countries.

It aims to improve laboratory-based surveillance of infectious diseases that have a major impact on public health

Launched by the Mérieux Foundation in 2008, GABRIEL network promotes collaboration in the field of infectious diseases and supports local responses to local health challenges through:

  • Collaborative research

    on acute respiratory infections, foodborne & waterborne diseases and TB

  • Technology transfer

    of diagnostic testing tools enables local laboratories to detect diseases

  • Training & knowledge-sharing

    empower local scientists so they can conduct autonomous research projects

This non-profit network brings together 19 research laboratories from academic and private institutions.

The GABRIEL network draws on the expertise of the Emerging Pathogens Laboratory (EPL) in Lyon, France, which supports member laboratories.

  • Highly trained staff and international standard laboratories (BSL2 and BSL3)
  • Strong ties with clinicians and local public health authorities
  • Expertise in viral and bacterial respiratory infections
  • Presence in zones with a high risk of epidemics from emerging diseases
  • 20 member laboratories and more than 70 scientists dedicated to GABRIEL research programs

Epidemiological surveillance and training

GABRIEL's aim is to build up the research capacities of local laboratories located in infectious disease hotspots in developing countries. The role of these laboratories is to ensure epidemiological surveillance, conduct research and deliver training.

Disease detection

Laboratory tests, used for the GABRIEL research programs, are designed to identify viruses, bacteria and biomarkers in a syndrome-based approach, using multiplex technologies. These tools are developed by the Emerging Pathogens Laboratory (EPL) and are transferred to the GABRIEL laboratories through its training programs.

The Emerging Pathogens Laboratory (EPL)

The EPL team seeks to improve research diagnostic tools to reduce infectious diseases in developing and emerging countries, combining research and training .The EPL team is interested in solutions for diagnosis and treatment in the surveillance of the infectious diseases, focusing on:

  • the identification and characterization of pathogens associated with infection
  • the host markers specifically induced by pathogens
  • the molecular and cellular biology of human pathogens associated with their risk factors

Targeting high-impact diseases

To launch their research activities, laboratories belonging to the network focus on diseases with a high public health impact, such as respiratory diseases, tuberculosis and enteric diseases. The network establishes strong ties with national institutions and is expected to provide support to national and international public health and research.